News

Filter

Current filters:

Cancidas

1 to 9 of 25 results

Merck & Co drug gets first nod under PIP

06-10-2008

The European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has made…

CancidasCaspofungin AcetateMerck KGaA

Merck & Co's Cancidas gets expanded US label

18-08-2008

US drug major Merck & Co says that the Food and Drug Administration has approved an expanded label for…

CancidasCaspofungin AcetateMerck KGaA

EMEA's PDCO issues PIP review opinions

04-02-2008

The European Medicines Agency's (EMEA) Pediatric Committee (PDCO) has adopted opinions on pediatric investigation…

CancidasCaspofungin AcetateCozaarHyzaarLosartan PotassiumLosartan Potassium-HydrochlorothiazideMerck KGaAMontelukast SodiumPfizerSingulair

Merck & Co returns to India

01-08-2005

US drug major Merck & Co has said that it will restart operations at its wholly-owned subsidiary MSD…

AggrastatCancidasCaspofungin AcetateErtapenem InjectionInvanzMerck KGaAPneumococcal Vaccine PolyvalentPneumovaxTirofibanVaricella Virus Vaccine LiveVarivax

Vicuron antifungal promising in Phase II

19-05-2003

Vicuron Pharmaceuticals, born out of the merger of Versicor with Biosearch Italia (Marketletters passim),…

AbelcetAmbisomeAmphotericin BAnidulafunginCancidasCaspofungin AcetateDiflucanEraxisFluconazoleFungizoneMerck KGaA

Vicuron files NDA for anidulafungin in USA

05-05-2003

Vicuron Pharmaceuticals of the USA, born out of the merger of Versicorwith Biosearch Italia (Marketletters…

AnidulafunginCancidasCaspofungin AcetateEraxisMerck KGaA

1 to 9 of 25 results

Back to top